CureBay Raises ₹62 Crore in Series A1 Funding Round Led by Elevar Equity
- ByStartupStory | January 12, 2024
Healthcare startup CureBay has secured ₹62 crore in its series A1 funding round, with Elevar Equity leading the investment. CureBay focuses on addressing primary healthcare challenges in remote areas through an innovative hybrid model.
With this fresh funding, CureBay aims to build a robust health data platform and recruit top-tier tech and healthcare talent.
Priyadarshi Mohapatra, the founder and CEO of CureBay, stated, “We’re investing in a data platform and data scientists because we believe we’re building one of the largest healthcare solutions. Additionally, we’re focusing on high-quality medical professionals, especially in the diagnostic and pharmacy areas. Our third investment area is creating a membership program to reduce patients’ out-of-pocket expenses.”
Follow Startup Story
Related Posts
